Fortfahren mit
EHU106911
MISSION® esiRNA
targeting human PFN1
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
20 μg | Versand in der Regel in 3 Wochen (4 bis 6 Wochen bei kundenspez. Bestellungen). | € 212,00 |
50 μg | Versand in der Regel in 3 Wochen (4 bis 6 Wochen bei kundenspez. Bestellungen). | € 382,00 |
Über diesen Artikel
€ 212,00
description
Powered by Eupheria Biotech
Quality Segment
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
ACGCCTACATCGACAACCTCATGGCGGACGGGACCTGTCAGGACGCGGCCATCGTGGGCTACAAGGACTCGCCCTCCGTCTGGGCCGCCGTCCCCGGGAAAACGTTCGTCAACATCACGCCAGCTGAGGTGGGTGTCCTGGTTGGCAAAGACCGGTCAAGTTTTTACGTGAATGGGCTGACACTTGGGGGCCAGAAATGTTCGGTGATCCGGGACTCACTGCTGCAGGATGGGGAATTTAGCATGGATCTTCGTACCAAGAGCACCGGTGGGGCCCCCACCTTCAATGTCACTGTCACCAAGACTGACAAGACGCTAGTCCTGCTGATGGGCAAAGAAGGTGTCCACGGTGGTTTGATCAACAAGAAATGTTATGAAATGGCCTCCCACCTTCGGCGTTCCCAGTACTGACCTCGTCTGTCCCTTC
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... PFN1(5216)
General description
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description targeting human PFN1 | description targeting human PFN2 | description targeting human PGM1 | description targeting human PFKFB4 |
| Gene Information human ... PFN1(5216) | Gene Information human ... PFN2(5217) | Gene Information human ... PGM1(5236) | Gene Information human ... PFKFB4(5210) |
| product line MISSION® | product line MISSION® | product line MISSION® | product line MISSION® |
| esiRNA cDNA target sequence ACGCCTACATCGACAACCTCATGGCGGACGGGACCTGTCAGGACGCGGCCATCGTGGGCTACAAGGACTCGCCCTCCGTCTGGGCCGCCGTCCCCGGGAAAACGTTCGTCAACATCACGCCAGCTGAGGTGGGTGTCCTGGTTGGCAAAGACCGGTCAAGTTTTTACGTGAATGGGCTGACACTTGGGGGCCAGAAATGTTCGGTGATCCGGGACTCACTGCTGCAGGATGGGGAATTTAGCATGGATCTTCGTACCAAGAGCACCGGTGGGGCCCCCACCTTCAATGTCACTGTCACCAAGACTGACAAGACGCTAGTCCTGCTGATGGGCAAAGAAGGTGTCCACGGTGGTTTGATCAACAAGAAATGTTATGAAATGGCCTCCCACCTTCGGCGTTCCCAGTACTGACCTCGTCTGTCCCTTC | esiRNA cDNA target sequence GGGCGTCTTTCAGAGCATTACGCCAATAGAAATAGATATGATTGTAGGAAAAGACCGGGAAGGTTTCTTTACCAACGGTTTGACTCTTGGCGCGAAGAAATGCTCAGTGATCAGAGATAGTCTATACGTCGATGGTGACTGCACAATGGACATCCGGACAAAGAGTCAAGGTGGGGAGCCAACATACAATGTGGCTGTCGGCAGAGCTGGTAGAGTCTTGGTCTTTGTAATGGGAAAAGAAGGGGTCCATGGAGGCGGATTGAATAAGAAGGCATACTCAATGGCAAAATACTTGAGAGACTCTGGGTTCTAGCTGCTAGGCAGACTGTTAAGTATTAGGGGAAAATTGCTCTTAAACTTTCCTAGCTATAAGCTTAAGTCTTAATTCTGGAAATTTTATTAGCAATGCAGGGTGATGGGGTATGAACCTG | esiRNA cDNA target sequence GGACCCATCCAAGTCATCTGATTGAAGAGCATGACAGAAACAAAATGTATTCACCAAGCATTTTAGGATTTGACTTTTTCACTAACCAGTTGACGAGCAGTGCATTTACAAGGCACTGCCAAACAAGATGCCCTTGGGAGCTGTGAGGGAAAGAGGACCTGCGGGCTTAGATCAATCTCAATTCCTTTTCATGCCCTCCTGCATTGCTGCTGCGTGGGTATTTGTCTCCTTAGCCATCAGGTACAGTTTACACTACAATGTAAGCTATAGGTGGAGCATCAGCAGTGAGTGAGGCCATTCTTCATCCTTAGGATGTGGCAATGAAATGATGGTGCAAGTTCCTTTCTCTTTTGTGAATCTTTCCCCCCATTTCCTGTTTACATGTAACCCAACAAAATGCAATTTCTAGTGCCTTCTGTCCAATCAGTTCTTTCCTCTGAGTGAGACGTACTTGGCTACAGATTTCTGCCTTGTTTTGCGA | esiRNA cDNA target sequence AGTGATGAGGCTACGGAGGACTTCATGAGGCGCATTGAGTGCTATGAGAACTCCTACGAGTCGCTAGATGAGGACCTGGATAGGGACCTGTCCTATATCAAGATCATGGATGTGGGCCAGAGCTACGTGGTGAACCGTGTGGCTGACCACATCCAGAGCCGCATCGTATATTACCTCATGAACATCCACGTGACCCCCCGCTCCATCTACCTCTGCCGGCACGGGGAGAGCGAGCTCAACCTCAAGGGCCGGATTGGCGGGGACCCAGGACTGTCCCCTCGGGGCAGGGAGTTTGCCAAGAGTCTAGCCCAGTTCATCAGTGACCAAAATATCAAGGATCTGAAGGTCTGGACAAGCCAGATGAAGAGGACAATCCAGACGGCTGAGGCACTGGGTGTGCCCTATGAACAGTGGA |
| Ensembl | human accession no. | Ensembl | human accession no. | Ensembl | human accession no. | Ensembl | human accession no. |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
| form lyophilized powder | form lyophilized powder | form lyophilized powder | form lyophilized powder |
Lagerklasse
10 - Combustible liquids
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.